PriceSensitive

Sugarbud (TSXV:SUGR) signs national supply agreement with Mendo Medical

Cannabis
TSXV:SUGR
22 February 2022 08:45 (EDT)

Source: Sugarbud Craft Growers

Sugarbud Craft Growers (SUGR) has signed a national supply agreement with Mendo Medical.

Under the terms of the agreement, Sugarbud will provide Mendo with a wide selection of its Craft Cannabis Collection for direct sale to registered medical patients nationwide via Mendo’s online medical cannabis sales platform.

The agreement is subject to customary regulatory, licensing and new product notification requirements.

Sugarbud President and CEO, John Kondrosky commented on the partnership.

“We are very pleased to be partnering with the Mendo team to provide registered medical patients across the country with access to our Craft Cannabis Collection.”

“Our expanded partnership with Mendo continues to leverage our existing production and reach to medical patients nationwide – while at the same time allowing Sugarbud to maintain the company’s primary focus and allocation of commercial resources on the continued scale up our core recreational cannabis business,” concluded Mr. Kondrosky

“We are delighted to work with Sugarbud to offer quality craft cannabis products to our members through our national sales portal accessible by medical patients from coast to coast,” said Jay Schwartz, Chief Operating Officer of Mendo. “We are excited to feature seven Sugarbud SKU’s that we think our patients will be eager to experience.”

Schwartz went on to add, “Providing Canadian cannabis patients, a platform to purchase a wide variety of sought-after products with accessible pricing will always be Mendo’s focus. Patients are our passion at Mendo and today’s announcement reflects that core value.”

Sugarbud is an Alberta-based, consumer-driven boutique craft cannabis company focused on the cultivation and production of cannabis products.

Sugarbud Craft Growers Corp. (SUGR) opened trading at C$1.35 per share.

Related News